Contact Us
Please Contact Us

toll free: 1800 3070 6727    Email: info@positivebioscience.com

PositiveScreen Lynch analyzes MSH6, MSH2, MLH1, PMS2, APC, MUTYH and EPCAM genes for mutations. MMR, MUTYH and APC gene mutation analyzed are associated with Lynch Syndrome/Hereditary Non-Polyposis Colorectal Cancer (HNPCC) syndrome. This test will help determine if a person has a significantly increased risk of developing lynch syndrome due to a mutation(s) in a cancer-predisposing gene(s). PositiveScreen Lynch is included in PositiveScreen Hereditary Cancer.

REPORTS:

Reports provides information that allows physicians to:

  • Better understand a patients’ risk for specific health conditions

  • Prescribe more suitable medications at optimal dosages for patients, as needed.

  • Suggest early lifestyle and diet interventions to help control or prevent certain health conditions.

BROCHURES: A SIMPLE GUIDE TO UNDERSTANDING

Related Test

  • PositiveProtectOnco

    Know risk to secondary cancers in Colorectal cancer patients who are positive for Lynch syndrome

    Determine risk of developing hereditary colorectal cancer in men and women

    Determine risk of developing hereditary uterine/endometrial cancer in women

    INR 331500
    INR 390000

  • PositiveProtectOnco

    Industry leading 51 gene tes

    Learn your risk for 11 cancers

    Know risk to secondary cancers in cancer patients

    INR 254150
    INR 299000

  • PositiveProtectOnco

    Sample Requirement: 3-4ml of Blood in myRisk kit

    NGS

    CAP and CLIA certified laboratory

    INR 287300
    INR 338000

Copyright ©2017 Positive Bioscience, Inc. All Rights Reserved